reference/12265434

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12265434

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	358
issn	1538-8514 1535-7163
issueIdentifier	2
pageRange	347-358
publicationName	Molecular Cancer Therapeutics
startingPage	347
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0352fa9dbf5677f98c9a97bb83d9d515 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_f88e6041e3072847a22baf05cdbc9c94 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e3c18600b59b2612497bf6b95256a2d6 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_ac20094810682758face5531e605f8b9 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c9715a34c9ccde7ccc72cadee3277b94
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_67b70f02131bfc1f9d83e8af9341c20a http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_09445123ca920c1c4b22650a979da27a http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_17fe8aa900d7fcfe85f06b1c757f871d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c99d8782a131a7727a1882714c05a092 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_db31c3f9658368e8b50b0935b2a0e8af http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e37c50b518ce213631d2a0437ed578e4
bibliographicCitation	Zhang C, Xu X, Trotter TN, Gowda PS, Lu Y, Suto MJ, Javed A, Murphy-Ullrich JE, Li J, Yang Y. Runx2 Deficiency in Osteoblasts Promotes Myeloma Resistance to Bortezomib by Increasing TSP-1-Dependent TGFβ1 Activation and Suppressing Immunity in Bone Marrow. Mol Cancer Ther. 2022 Feb;21(2):347–58. PMID: 34907087; PMCID: PMC8828708.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66111056b36602915f7b98dad697bc8b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_29275a75542c9617b8e57a613e770e0e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ad02f583ac9d197d9c0f2636a386e0eb http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8682-8313 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bcd71cef7276ea280cf764a3f4e43763 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7cf948d1fe157b0f3c3f7ad07ace6141 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7863-0737 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4785-3401 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_097c385f43a6a25655a7115dce1d31f8
date	2022-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC8828708 https://pubmed.ncbi.nlm.nih.gov/34907087 https://doi.org/10.1158/1535-7163.mct-21-0310
isPartOf	https://portal.issn.org/resource/ISSN/1535-7163 https://portal.issn.org/resource/ISSN/1538-8514 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30097
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Runx2 Deficiency in Osteoblasts Promotes Myeloma Resistance to Bortezomib by Increasing TSP-1–Dependent TGFβ1 Activation and Suppressing Immunity in Bone Marrow
discusses	http://id.nlm.nih.gov/mesh/M0276678 http://id.nlm.nih.gov/mesh/M0350110 http://id.nlm.nih.gov/mesh/M0477045 http://id.nlm.nih.gov/mesh/M0024760 http://id.nlm.nih.gov/mesh/M0496358 http://id.nlm.nih.gov/mesh/M0029254
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D050659Q000172 http://id.nlm.nih.gov/mesh/D053773Q000378 http://id.nlm.nih.gov/mesh/D009101Q000188 http://id.nlm.nih.gov/mesh/D009101Q000235 http://id.nlm.nih.gov/mesh/D010006Q000378 http://id.nlm.nih.gov/mesh/D000069286Q000627 http://id.nlm.nih.gov/mesh/D019700Q000378 http://id.nlm.nih.gov/mesh/D001853Q000378
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D009101Q000473 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D000069286Q000494 http://id.nlm.nih.gov/mesh/D004195 http://id.nlm.nih.gov/mesh/D051379
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3385 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8530 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c70a618a16ab1922770fa8a0c5190e04 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID387447 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8561 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_25dd6a52e9ad20f76126de5c13624149 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.25.1 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Total number of triples: 72.